| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is focusing on significant manufacturing expansion to boost production capacity for its obesity drug, showcasing a strong confidence in market demand. However, recent setbacks, including the halting of drug trials and research and development challenges, indicate potential risks in their product development trajectory. While the company is actively launching new drugs, these developments are tempered by the negative implications of failed trials. The balance of ambitious growth and inherent product development challenges defines their current landscape. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.2, and the negative at -0.2 on 2025-09-26. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (1.4) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-26 | 0%(0%) | 0 | 0% | 0.1 | 1.4 | 6 | |||||||
| 2025-09-25 | 0%(0%) | 0 | 0% | -0.1 | 0.5 | -6 | |||||||
| 2025-09-24 | 0%(0%) | 0 | 0% | 0.1 | 1.6 | -1 | |||||||
| 2025-09-23 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | 5.5 | |||||||
| 2025-09-22 | 0%(0%) | 0 | 0% | 0 | 1.1 | -1 | |||||||
| 2025-09-21 | 0%(0%) | 0 | 0% | -0.1 | 0.6 | -1 | |||||||
| 2025-09-20 | 0%(0%) | 0 | 0% | -0.1 | 0.6 | -1 | |||||||
| 2025-09-18 | 0%(0%) | 0 | 0% | -0.1 | 0.6 | -1 | |||||||
| 2025-09-14 | 0%(0%) | 0 | 0% | 0.2 | 2.1 | -1 | |||||||
| 2025-09-10 | 0%(0%) | 0 | 0% | -0 | 0.9 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-09-26 17:02:44 The potential impact of governmental policies and international competition in the biotechnology and pharmaceutical sectors affecting stock market reactions. |
| 2025-09-26 17:02:44 Increased attention from analysts and investors toward Eli Lilly indicates a growing confidence in the company's future prospects. |
| 2025-09-26 17:02:44 Eli Lilly's opening of the Gateway Labs site in San Diego represents significant investment in the biotechnology ecosystem and support for early-stage companies. |
| 2025-09-26 17:02:44 The advancement of Eli Lilly stock prices, showing a positive trend linked to new product approvals and market interest. |
| 2025-09-26 17:02:44 Eli Lilly's Kisunla (donanemab) receiving marketing authorization from the European Commission highlights the positive regulatory environment for innovative Alzheimer's treatments. |
| 2025-09-26 09:28:49 The tariffs introduce regulatory changes that could affect pharmaceutical pricing structures and market access. |
| 2025-09-26 09:28:49 Certain companies are poised to benefit from the tariff, creating disparities in stock performance among pharmaceutical companies. |
| 2025-09-26 09:28:49 The tariff has triggered a $270 billion surge in industry investments, indicating positive market responses from companies like Eli Lilly. |
| 2025-09-26 09:28:49 The implementation of a 100% pharmaceutical tariff is expected to significantly impact the pharmaceutical industry, leading to shifts in investment and market dynamics. |